Regulation of the cerebrovascular smooth muscle cell phenotype by mitochondrial oxidative injury and endoplasmic reticulum stress in simulated microgravity rats via the PERK-eIF2α-ATF4-CHOP pathway

Biochim Biophys Acta Mol Basis Dis. 2020 Aug 1;1866(8):165799. doi: 10.1016/j.bbadis.2020.165799. Epub 2020 Apr 15.

Abstract

Microgravity exposure results in vascular remodeling and cardiovascular dysfunction. Here, the effects of mitochondrial oxidative stress on vascular smooth muscle cells (VSMCs) in rat cerebral arteries under microgravity simulated by hindlimb unweighting (HU) was studied. Endoplasmic reticulum (ER)-resident transmembrane sensor proteins and phenotypic markers of rat cerebral VSMCs were examined. In HU rats, CHOP expression was increased gradually, and the upregulation of the PERK-eIF2α-ATF4 pathway was the most pronounced in cerebral arteries. Furthermore, PERK/p-PERK signaling, CHOP, GRP78 and reactive oxygen species were augmented by PERK overexpression but attenuated by the mitochondria-targeting antioxidant MitoTEMPO. Meanwhile, p-PI3K, p-Akt and p-mTOR protein levels in VSMCs were increased in HU rat cerebral arteries. Compared with the control, HU rats exhibited lower α-SMA, calponin, SM-MHC and caldesmon protein levels but higher OPN and elastin levels in cerebral VSMCs. The cerebral VSMC phenotype transition from a contractile to synthetic phenotype in HU rats was augmented by PERK overexpression and 740Y-P but reversed by MitoTEMPO and the ER stress inhibitors tauroursodeoxycholic acid (TUDCA) and 4-phenylbutyric acid (4-PBA). In summary, mitochondrial oxidative stress and ER stress induced by simulated microgravity contribute to phenotype transition of cerebral VSMCs through the PERK-eIF2a-ATF4-CHOP pathway in a rat model.

Keywords: Endoplasmic reticulum stress; Hindlimb unweighting; Mitochondria; Oxidative stress; Phenotype of vascular smooth muscle cells; Vascular remodeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 4 / genetics*
  • Activating Transcription Factor 4 / metabolism
  • Animals
  • Antioxidants / pharmacology
  • Cerebral Arteries / cytology
  • Cerebral Arteries / drug effects
  • Cerebral Arteries / metabolism*
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / genetics
  • Endoplasmic Reticulum / metabolism
  • Eukaryotic Initiation Factor-2 / genetics*
  • Eukaryotic Initiation Factor-2 / metabolism
  • Gene Expression Regulation
  • Heat-Shock Proteins / genetics
  • Heat-Shock Proteins / metabolism
  • Hindlimb Suspension
  • Male
  • Mitochondria / drug effects
  • Mitochondria / genetics
  • Mitochondria / metabolism
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Myocytes, Smooth Muscle / cytology
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism*
  • Organophosphorus Compounds / pharmacology
  • Phenylbutyrates / pharmacology
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Piperidines / pharmacology
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / metabolism
  • Taurochenodeoxycholic Acid / pharmacology
  • Transcription Factor CHOP / genetics*
  • Transcription Factor CHOP / metabolism
  • eIF-2 Kinase / genetics*
  • eIF-2 Kinase / metabolism

Substances

  • Antioxidants
  • Atf4 protein, rat
  • Ddit3 protein, rat
  • Eukaryotic Initiation Factor-2
  • GRP78 protein, rat
  • Heat-Shock Proteins
  • MitoTEMPO
  • Organophosphorus Compounds
  • Phenylbutyrates
  • Piperidines
  • Activating Transcription Factor 4
  • Transcription Factor CHOP
  • Taurochenodeoxycholic Acid
  • ursodoxicoltaurine
  • 4-phenylbutyric acid
  • mTOR protein, rat
  • PERK kinase
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • eIF-2 Kinase